A Clinical trial to study the effect of Sirupeelaiyathi Kudineer in patients with Kidney stones(Kalladaippu)

Clinical Evaluation of Sirupeelayathi Kudineer in the Management of Kalladaippu(Urolithiasis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010966

Enrollment

Registered

2017-12-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Urolithiasis Health Condition 2: N20-N23- Urolithiasis Health Condition 3: N20-N23- Urolithiasis

Interventions

Intervention1: Sirupeelayathi Kudineer: 30-50ml of decoction for 45 days twice daily Control Intervention1: Not Applicable: 0

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presence of any three following signs and symptoms; a)Intermittent dull colicky pain(groin to loin) b)Hematuria c)Frequent micturition d)Burning micturition. 2.Evidence of calculus in X-Ray(KUB region) and Ultrasonogram (KUB)region. 3)Patients with calculi of size 3mm to 10mm

Exclusion criteria

Exclusion criteria: 1.Stag horn calculi 2.H/o.DM,HT,PT,CVD 3.Severe UTI 4.Pregnant and lactating women 5.Hydronephrosis 6.Pyelonephrosis 7.Cystitis

Design outcomes

Primary

Measure	Time frame
Absence or reduction in size/no.of stones,Reduction of presence of pus cells,epithelial cells, RBCs and calcium oxalate crystals in urine at 45th day of trialTimepoint: Absence or reduction in size/no.of stones,Reduction of presence of pus cells,epithelial cells, RBCs and calcium oxalate crystals in urine at 45th day of trial	—

Secondary

Measure	Time frame
Assessing the safety of trial drugTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr V Vijaya Kumar

Central Council for Research in Siddha,Chennai.

rrisiddha@yahoo.co.in04132245072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026